Background The high incidence of epidermal growth factor receptor (EGFR) mutations is
usually found in female patients with lung adenocarcinoma who have never-smoked …

Background EGFR mutation-induced cell proliferation causes changes in tumor biology and
tumor metabolism, which may reflect tumor marker concentration and 18F-FDG uptake on …

Objective Epidermal growth factor receptors (EGFR) mutation status is crucial for the
prediction of a tumour response to treatment with EGFR tyrosine kinase (EGFR‐TK) …

Objective To explore the clinicopathological features associated with epidermal growth
factor receptor (EGFR) gene mutation in non-small cell lung cancer (NSCLC) patients …

Objective: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) can
effectively control non-small cell lung cancer (NSCLC). Therefore, EGFR mutations should …

Objectives: To discover the incidence and characteristics of EGFR mutations in non-small
cell lung cancer (NSCLC) in a single, large cohort as a part of routine diagnostic …

Background Several clinical and preclinical studies suggest that non–small cell lung
cancers (NSCLCs) with EGFR compound mutations were associated with lower efficacies of …

Introduction Testing for the epidermal growth factor receptor (EGFR) gene mutations
requires considerable multidisciplinary experience of clinicians (for appropriate patient …

Background Lung cancer is the most common type of cancer worldwide with an estimation of
1.82 million new cancer cases diagnosed; and it is the leading cause of cancer-related …

Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …